Belgium (BE)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway (2024) Gong M, Li J, Qin Z, Machado Bressan Wilke MV, Liu Y, Li Q, Liu H, et al. Journal article Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group (2024) Elsayad K, Guenova E, Assaf C, Nicolay JP, Trautinger F, Stadler R, Waldstein C, et al. Journal article, Review article Dynamic traction force measurements of migrating immune cells in 3D biopolymer matrices (2024) Böhringer D, Cóndor M, Bischof L, Czerwinski T, Gampl N, Ngo AP, Bauer A, et al. Journal article Sclerosing mucoepidermoid carcinoma of salivary glands (2024) Othman BK, Bradová M, Simpson RH, Laco J, Agaimy A, Rito M, Ihrler S, et al. Journal article In Regard to Shaitelman et al. (2024) Kaidar-Person O, Strnad V, Ratosa I, Boersma L, Poortmans P Journal article Corrigendum to “Nuclear charge radii of germanium isotopes around N = 40” [Physics Letters B, 856 (2024)138867] (Physics Letters B (2024) 856, (S0370269324004258), (10.1016/j.physletb.2024.138867)) (2024) Wang SJ, Kanellakopoulos A, Yang XF, Bai SW, Billowes J, Bissell ML, Blaum K, et al. Journal article, Erratum Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article EANS Epilepsy surgery Brain Dissection Course Vienna 2024 (2024) Rössler K, Van Roost D, Schijns O, Ackermans L, Delev D, Batista PD, Erőss L, et al. Journal article A Novel Approach to the Evaluation of Groups: Type of Group and Facet of Evaluation Matter (2024) Barbedor J, Scheider J, Yzerbyt V, Abele-Brehm A Journal article The tyrosine kinase Yes1 is a druggable host factor of HEV (2024) Haase JA, Baheerathan A, Zhang X, Fu RM, Nocke MK, Decker C, Dao Thi VL, et al. Journal article